Skip to Main Content

NISH (NITAG Support Hub) 3: Malaria vaccines: Kenya

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the RTS,S/AS01 malaria vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Malaria vaccine

Hoyt, J., Okello, G., Bange, T., Kariuki, S., Jalloh, M. F., Webster, J., & Hill, J. (2023). RTS,S/AS01 malaria vaccine pilot implementation in western Kenya: a qualitative longitudinal study to understand immunisation barriers and optimise uptake. BMC public health, 23(1), 2283. 

DOI: 10.1101/2023.11.22.23298907

Hill, J., Bange, T., Hoyt, J., Kariuki, S., Jalloh, M. F., Webster, J., & Okello, G. (2024). Integration of the RTS,S/AS01 malaria vaccine into the Essential Programme on Immunisation in western Kenya: a qualitative longitudinal study from the health system perspective. The Lancet. Global health, 12(4), e672–e684. DOI: 10.1016/S2214-109X(24)00013-5
 
Galactionova, K., Bertram, M., Lauer, J. and Tediosi, F., 2015. Costing RTS, S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: a generalizable approach drawing on publicly available data. Vaccine, 33(48), pp.6710-6718.
https://doi.org/10.1016/j.vaccine.2015.10.079
 
PATH, Liverpool School of Tropical Medicine (Kenya), Malawi-Liverpool Wellcome Trust (Malawi), & University of Health and Allied Sciences (Ghana). (2022). Health Utilisation Study (HUS) Round 2 - cross-country report on findings from the Primary Child Caregiver cohort sample. Zenodo. https://doi.org/10.5281/zenodo.6395820